Search Results - Antonio Calles

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
    Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines

    Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines by Antonio Calles, Nicholas Kwiatkowski, Bernard K. Cammarata, Dalia Ercan, Nathanael S. Gray, Pasi A. Jänne

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer

    Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer by Ana Custodio, J.L. González-Larriba, Jana Bobokova, Antonio Calles, Rafael Álvarez, Eugenio Cuadrado, Aránzazu Manzano, Eduardo Díaz‐Rubio

    Published 2009
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey

    Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey by Roberto Collado‐Borrell, Vicente Escudero‐Vilaplana, Antonio Calles, Estela García-Martín, Belén Marzal-Alfaro, Eva González-Haba, Ana Herranz‐Alonso, María Sanjurjo‐Sáez

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Prioritizing Phase I Treatment Options Through Preclinical Testing on Personalized Tumorgraft

    Prioritizing Phase I Treatment Options Through Preclinical Testing on Personalized Tumorgraft by Maria Pia Morelli, Emiliano Calvo, E. Ordonez Ordonez, Michael J. Wick, Belen-Rubio Viqueira, Pedro P. López‐Casas, Elizabeth Bruckheimer, Antonio Calles, David Sidransky, Manuel Hidalgo

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in <i>KRAS</i>-Mutant Lung Adenocarcinoma

    Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in <i>KRAS</i>-Mutant Lung Adenocarcinoma by Antonio Calles, Lynette M. Sholl, Scott J. Rodig, Ashley K. Pelton, Jason L. Hornick, Mohit Butaney, Christine Lydon, Suzanne E. Dahlberg, Geoffrey R. Oxnard, David M. Jackman, Pasi A. Jänne

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer

    Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer by Antonio Calles, Xiaoyun Liao, Lynette M. Sholl, Scott J. Rodig, Gordon J. Freeman, Mohit Butaney, Christine Lydon, Suzanne E. Dahlberg, F. Stephen Hodi, Geoffrey R. Oxnard, David M. Jackman, Pasi A. Jänne

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior

    Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior by Beatriz Pérez‐Villamil, Alejandro Romera Lopez, Susana Prieto, Guillermo López–Campos, Antonio Calles, Jose Antonio Lopez Asenjo, Julián Sanz‐Ortega, Cristina Fernández, Javier Sastre, Rosario Alfonso, Trinidad Caldés, Fernando Martín-Sánchez, Eduardo Díaz‐Rubio

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors

    Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors by Takayuki Kosaka, Junko Tanizaki, Raymond M. Paranal, Hideki Endoh, Christine Lydon, Marzia Capelletti, Claire E. Repellin, Jihyun Choi, Atsuko Ogino, Antonio Calles, Dalia Ercan, Amanda J. Redig, Magda Bahcall, Geoffrey R. Oxnard, Michael J. Eck, Pasi A. Jänne

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment

    Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment by Elena Garralda, Keren Paz, Pedro P. López‐Casas, Siân Jones, Amanda Katz, Lisa Kann, Fernando López‐Ríos, Francesca Sarno, Fátima Al‐Shahrour, David Vásquez, Elizabeth Bruckheimer, Samuel V. Angiuoli, Antonio Calles, Luis A. Díaz, Victor E. Velculescu, Alfonso Valencia, David Sidransky, Manuel Hidalgo

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors

    Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors by Dejan Juric, Rodrigo Dienstmann, Andrés Cervantes, Manuel Hidalgo, Wells A. Messersmith, George R. Blumenschein, Josep Tabernero, Desamparados Roda, Antonio Calles, Antonio Jimeno, Xiaodong Wang, Sandra Sanabria Bohórquez, Cecilia Leddy, Catherine Littman, Amy V. Kapp, David S. Shames, Elicia Penuel, Lukas C. Amler, Andrea Pirzkall, José Baselga

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer

    A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer by Frederick H. Wilson, Cory M. Johannessen, Federica Piccioni, Pablo Tamayo, Jong Wook Kim, Eliezer M. Van Allen, Steven M. Corsello, Marzia Capelletti, Antonio Calles, Mohit Butaney, Tanaz Sharifnia, Stacey B. Gabriel, Jill P. Mesirov, William C. Hahn, Jeffrey A. Engelman, Matthew Meyerson, David E. Root, Pasi A. Jänne, Levi A. Garraway

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: real-world data from a European cohort

    Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progres... by Giulio Metro, Alfredo Addeo, Diego Signorelli, Alessio Gili, Panagiota Economopoulou, Fausto Roila, Giuseppe Luigi Banna, Alessandro De Toma, Juliana Rey Cobo, Andrea Camerini, Athina Christopoulou, Giuseppe Lo Russo, Marco Banini, Domenico Galetta, Beatriz Jiménez, Ana Collazo-Lorduy, Antonio Calles, Panagiotis Baxevanos, Helena Linardou, P. Kosmidis, Marina Chiara Garassino, Giannis Mountzios

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study

    Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study by Glenn J. Hanna, Naifa L. Busaidy, Nicole G. Chau, Lori J. Wirth, Justine A. Barletta, Antonio Calles, Robert I. Haddad, Stefan Kraft, Maria E. Cabanillas, Guilherme Rabinowits, Anne O’Neill, Sewanti Limaye, Erik K. Alexander, Francis D. Moore, Krystof Misiwkeiwicz, Tom Thomas, Matthew A. Nehs, Ellen Marqusee, Stephanie L. Lee, Pasi A. Jänne, Jochen H. Lorch

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

    UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN) by Jair Bar, Nir Peled, Shiruyeh Schokrpur, Mirjana Wolner, Ofer Rotem, Nicolas Girard, Frank Aboubakar Nana, Sofie Derijcke, Waleed Kian, Sandip Pravin Patel, Hadas Gantz-Sorotsky, Alona Zer, Mor Moskovitz, Giulio Metro, Yakir Rottenberg, Antonio Calles, Maximilian J. Hochmair, Kristof Cuppens, Lynn Decoster, Martin Reck, Dror Limon, Estelamari Rodríguez, Christoforos Astaras, Adrienne Bettini, Simon Häfliger, Alfredo Addeo

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Lung cancer patients with COVID-19 in Spain: GRAVID study

    Lung cancer patients with COVID-19 in Spain: GRAVID study by Mariano Provencio, José María Mazarico Gallego, Antonio Calles, Mónica Antoñanzas, Cristina Pangua, Xabier Mielgo-Rubio, Ernest Nadal, Rafael López Castro, Ana López, E. del Barco, Manuel Dómine, Fernando Franco, Pilar Díz, Carmen Sandoval, Èlia Sais, Ivana Sullivan, M.A. Sala, Gema García Ledo, Marc Cucurull, Joaquín Mosquera, Mireia Martínez, L.E. Chara, Edurne Arriola, B. Esteban Herrera, José Ramón Jarabo, Rosa Álvarez, Javier Baena, María González Cao

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

    Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program by Oliver Illini, Maximilian J. Hochmair, Hannah Fabikan, Christoph Weinlinger, Amanda Tufman, Aurélie Swalduz, Kristina Lamberg, Sayed M.S. Hashemi, Florian Huemer, Anders Vikström, Martin Wermke, Gudrun Absenger, Alfredo Addeo, Shantanu Banerji, Antonio Calles, Stephen Clarke, Massimo Di Maïo, Alice Durand, M. Duruisseaux, Malinda Itchins, Okko-Sakari Kääränien, Florian Krenn, Eckart Laack, Adrianus J. de Langen, Katja Mohorčič, Georg Pall, Antonio Passaro, G. Prager, Achim Rittmeyer, J. Rothenstein, Michael A. Schumacher, Ewald Wöll, Arschang Valipour

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

    RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion by Mihaela Aldea, Arianna Marinello, M. Duruisseaux, Wael Zrafi, Nicole Conci, Giacomo Massa, Giulio Metro, I. Monnet, Patricia Iranzo, Fabrizio Tabbò, Emilio Bria, Florian Guisier, Damien Vasseur, Colin R. Lindsay, Santiago Ponce-Aix, Sophie Cousin, Fabrizio Citarella, Vincent Fallet, J.N. Minatta, Anna Eisert, Hortense de Saint Basile, Clarisse Audigier-Valette, Laura Mezquita, Antonio Calles, Giannis Mountzios, Marco Tagliamento, J. Remon Masip, Judith Raimbourg, Safae Terrisse, Alessandro Russo, Diego Cortinovis, Philippe Rochigneux, David J. Pinato, Alessio Cortellini, Camille Léonce, Anas Gazzah, Maria‐Rosa Ghigna, Roberto Ferrara, Filippo Gustavo Dall’Olio, Francesco Passiglia, Vienna Ludovini, Fabrice Barlési, Enriqueta Felip, David Planchard, Benjamin Besse

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis

    Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis by Paaladinesh Thavendiranathan, Lili Zhang, Amna Zafar, Zsófia D. Drobni, Syed Mahmood, Marcella Cabral, Magid Awadalla, Anju Nohria, Daniel A. Zlotoff, Franck Thuny, Lucie Heinzerling, Ana Barac, Ryan J. Sullivan, Carol L. Chen, Dipti Gupta, Michael C. Kirchberger, Sarah Hartmann, Jonathan W. Weinsaft, Hannah Gilman, Muhammad A. Rizvi, Bojan Kovacina, Caroline Michel, Gagan Sahni, Ana González‐Mansilla, Antonio Calles, Francisco Fernández‐Avilés, Michael Mahmoudi, Kerry L. Reynolds, Sarju Ganatra, Juán José Gavira, Nahikari Salterain González, M. Castro, Raymond Y. Kwong, Michael Jerosch‐Herold, Otávio R. Coelho‐Filho, Jonathan Afilalo, Eduardo Zataraín-Nicolás, A. John Baksi, Bernd J. Wintersperger, Oscar Calvillo‐Argüelles, Stéphane Éderhy, En‐Hua Yang, Alexander R Lyon, Michael G. Fradley, Tomas G. Neilan

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis

    Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis by Thiago Quinaglia, Carlos A. Gongora, Magid Awadalla, M Hassan, Amna Zafar, Zsófia D. Drobni, Syed Mahmood, Lili Zhang, Otávio R. Coelho‐Filho, Giselle Alexandra Suero-Abreu, Muhammad A. Rizvi, Gagan Sahni, Anant Mandawat, Eduardo Zataraín-Nicolás, Michael Mahmoudi, Ryan J. Sullivan, Sarju Ganatra, Lucie Heinzerling, Franck Thuny, Stéphane Éderhy, Hannah Gilman, Supraja Sama, Sofia Nikolaidou, Ana González Mansilla, Antonio Calles, Marcella Cabral, Francisco Fernández‐Avilés, Juán José Gavira, Nahikari Salterain González, M. Castro, Ana Barac, Jonathan Afilalo, Daniel A. Zlotoff, Leyre Zubiri, Kerry L. Reynolds, Richard B. Devereux, Judy Hung, Michael H. Picard, Eric H. Yang, Dipti Gupta, Caroline Michel, Alexander R. Lyon, Carol L. Chen, Anju Nohria, Michael G. Fradley, Paaladinesh Thavendiranathan, Tomas G. Neilan

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer

    RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer by David R. Spigel, Afshin Dowlati, Yuanbin Chen, Alejandro Navarro, James Chih‐Hsin Yang, Goran Stojanović, Maria Jové, Patricia Rich, Zoran Andrić, Yi‐Long Wu, Charles M. Rudin, Huanyu Chen, Li Zhang, Stanley M.H. Yeung, Fawzi Benzaghou, Luis Paz‐Ares, Paul A. Bunn, Philip Clingan, Theresa Hayes, Craig Underhill, Wim Demey, Frédéric Forget, Marc Lambrechts, Kristiaan Nackaerts, Fabio André Franke, Alan A. Azambuja, Rodrigo Régnier Chemim Guimarães, Josiane Mourão Dias, Víctor Sacristán Santos, Bruno Cezar de Mendonça Uchôa, Gustavo Vasconcelos Alves, Cláudia Vaz de Melo Sette, Minghong Bi, Jiuwei Cui, Jian Fang, Jianhua Shi, Ke Wang, Zhen Wang, Xinmin Yu, C. Dayen, Laurent Greillier, Gilles Quéré, Alexander Baraniskin, Helge Bischoff, Frank Griesinger, Cornelius F. Waller, Tibor Csőszi, Gabriella Gálffy, Ibolya Laczó, György Losonczy, S. Tehenes, Angelo Delmonte, Alessandro Follador, Halina Batura‐Gabryel, Piotr Centkowski, Iwona Danielewicz, Andrzej Każarnowicz, Rodryg Ramlau, Alina Muntean, Cristina Oprean, Michael Schenker, Cristina Tiut, Anghel Adrian Udrea, Andrei Ungureanu, Nina Karaseva, Nikolay Kislov, Elena Poddubskaya, Irina Rozhkova, Ekaterina Solovyeva, Anastasia Zimina, Zoran Andrić, Vladimir Kovčin, Marina Petrović, Zorica Radojević, Goran Stojanović, SookHee Hong, Sang‐We Kim, Ki Hyeong Lee, Byoung Yong Shim, M. Alonso Garcìa, Antonio Calles, Vanesa Gutiérrez Calderón, Óscar Juan, B. Massuti Sureda, Alejandro Navarro, Ramón Palmero, Luis Paz-Ares Rodríguez, Ching-Liang Ho, Sheng‐Hao Lin, Chien‐Ying Liu, James Chih‐Hsin Yang, İrfan Çiçin, Mahmut Gümüş, Hakan Harputluoğlu, Mustafa Özgüroğlu, S. Seber, Ahmet Sezer, Hryhoriy Adamchuk, Igor Bondarenko, Yevhen Hotko

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: